LINC00491: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC00491

NCBI ID: G285708

LINC00491

Other Name(s): long intergenic non-protein coding RNA 491 | Long intergenic non-protein coding RNA 491, transcript variant 1

LINC00491: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC00491 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as a potential drug target and biomarker. It is a non-coding RNA molecule that is expressed in various tissues and cells throughout the body. LINC00491 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

Drug Target Potential

LINC00491 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. One of the key features of LINC00491 is its ability to interact with various proteins, including tyrosine kinases. This interaction suggests that LINC00491 could be a useful target for small molecule inhibitors, which could potentially inhibit the activity of these proteins and lead to cellular responses.

In addition to its potential as a drug target, LINC00491 has also been shown to be a potential biomarker for various diseases. For example, LINC00491 has been shown to be downregulated in various diseases, including cancer, and has been shown to be upregulated in cancer cells. This suggests that LINC00491 could be a useful biomarker for cancer diagnosis and treatment.

Expression and Localization

LINC00491 is a highly expressed lncRNA that is expressed in various tissues and cells throughout the body. It has been shown to be expressed in tissues such as the brain, heart, and liver, and has been shown to localize to the cytoplasm.

Function and Interaction

LINC00491 has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. It has been shown to regulate the activity of several tyrosine kinases, including FGFR1 and PDGFR, which are involved in cell signaling.

In addition to its role in cell signaling, LINC00491 has also been shown to play a role in the regulation of protein translation. This suggests that LINC00491 may be involved in the regulation of protein synthesis and may be a potential target for small molecule inhibitors.

Conclusion

In conclusion, LINC00491 is a long intergenic non-protein-coding RNA that has been identified as a potential drug target and biomarker. Its unique structure and its involvement in various cellular processes make it an attractive target for small molecule inhibitors. Further research is needed to determine the full function and interaction of LINC00491 and to explore its potential as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 491

The "LINC00491 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00491 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets